W
Winfried Häuser
Researcher at Technische Universität München
Publications - 389
Citations - 19998
Winfried Häuser is an academic researcher from Technische Universität München. The author has contributed to research in topics: Fibromyalgia & Chronic pain. The author has an hindex of 61, co-authored 361 publications receiving 15838 citations. Previous affiliations of Winfried Häuser include University of Duisburg-Essen.
Papers
More filters
Journal ArticleDOI
Erratum zu: Opioide bei chronischen nicht-tumorbedingten Schmerzen – sind sie Nichtopioidanalgetika überlegen?: Systematische Übersicht und Metaanalyse der Wirksamkeit, Verträglichkeit und Sicherheit in randomisierten Direktvergleichen von Opioiden und Nichtopioidanalgetika über mindestens 4 Wochen
Journal ArticleDOI
Comment on: Diagnosis of fibromyalgia: comparison of the 2011/2016 ACR and AAPT criteria and validation of the modified Fibromyalgia Assessment Status: reply.
Fausto Salaffi,Marco Di Carlo,Sonia Farah,Fabiola Atzeni,Dan Buskila,Jacob N. Ablin,Winfried Häuser,Piercarlo Sarzi-Puttini +7 more
TL;DR: There is a considerable agreement between criteria-based diagnoses of FM, although the AAPT Cr perform least well in terms of percentage of correct classification.
Journal ArticleDOI
Social security work disability and its predictors in patients with fibromyalgia.
TL;DR: To determine prevalence and incidence of US Social Security Disability and Supplemental Security Income in patients with fibromyalgia and to investigate prediction of SSD.
Journal ArticleDOI
Systematic reviews with meta-analysis on cannabis-based medicines for chronic pain - a methodological and political minefield
TL;DR: Public interest in cannabis products for medical purposes has been widely advocated, with legalization for recreational and medical use in North America and some European countries.
Journal ArticleDOI
[Validation of the German version of the Inflammatory Bowel Disease Questionnaire (Competence Network IBD, IBDQ-D)].
TL;DR: The Inflammatory Bowel Disease Questionnaire (IBDQ) is the standard disease-specific instrument for assessment of health-related quality of life (HRQOL) in patients with inflammatory bowel diseases ( IBD).